Alvotech (ALVO) Beginning Cash Balance (2022 - 2026)
Alvotech's (ALVO) quarterly Beginning Cash Balance came in at $172.4 million in Q1 2026, up 235.15% YoY from $51.4 million in Q1 2025, and up 435.48% on a QoQ basis from -$51.4 million in Q3 2025.
Alvotech (ALVO) Beginning Cash Balance (2022 - 2026) Analysis & Trends
Alvotech (ALVO) has 5 years of Beginning Cash Balance data on file, last reported at $172.4 million in Q1 2026.
- Quarterly Beginning Cash Balance rose 235.15% year-over-year to $172.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $172.4 million (up 46.28% YoY) and the FY2023 annual result came in at $66.4 million, changed N/A from the prior year.
- Beginning Cash Balance advanced to $172.4 million in Q1 2026, from -$51.4 million in the prior quarter.
- In the past five years, Beginning Cash Balance ranged from a high of $172.4 million in Q1 2026 to a low of -$51.4 million in Q3 2025.
- A 5-year average of $36.6 million and a median of $17.6 million in 2022 frame the typical range for Beginning Cash Balance.
- Annual changes were most pronounced in 2023 — Beginning Cash Balance soared 278.37% — and 2025, when it plunged 360.95%.
- Tracing ALVO's Beginning Cash Balance over 5 years: stood at $17.6 million in 2022, then soared by 278.37% to $66.4 million in 2023, then slumped by 83.2% to $11.2 million in 2024, then plunged by 560.49% to -$51.4 million in 2025, then jumped by 435.48% to $172.4 million in 2026.
- The last three Beginning Cash Balance figures came in at $172.4 million (Q1 2026), -$51.4 million (Q3 2025), and $51.4 million (Q1 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - |
| 10 | Alvotech | 1.26 Bn | 1.26 Bn | 5.09 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 172.36 Mn |
| Mar 31, 2026 | 172.36 Mn |
| Sep 30, 2025 | -51.38 Mn |
| Sep 30, 2025 | -51.38 Mn |
| Mar 31, 2025 | 51.43 Mn |
| Mar 31, 2025 | 51.43 Mn |
| Dec 31, 2024 | 11.16 Mn |
| Dec 31, 2024 | 11.16 Mn |
| Sep 30, 2024 | -11.15 Mn |
| Sep 30, 2024 | -11.15 Mn |
| Dec 31, 2023 | 66.43 Mn |
| Dec 31, 2023 | 66.43 Mn |
| Dec 31, 2022 | 17.56 Mn |
| Dec 31, 2022 | 17.56 Mn |